This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n9https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57200151
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в листопаді 2010 wetenschappelijk artikel im November 2010 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2010
p:P577
wds:Q57200151-7BD1EA4F-63C8-46BD-A3A6-84DC7EFADB9E
wdt:P577
2010-11-18T00:00:00Z
p:P2888
wds:Q57200151-83EC3DBB-6858-4B7B-8EED-B6CF126ADBFA
wdt:P2888
n9:s10637-010-9586-0
p:P2860
wds:Q57200151-385F31BD-A609-4722-9A9E-7B4F6BC51920 wds:Q57200151-394544C8-4948-4417-9B91-29CBB6FC3A70 wds:Q57200151-3BE6DCD3-1202-4B28-81D7-5F4A475048CB wds:Q57200151-3522FECA-37F0-4D95-8758-44F31D417502 wds:Q57200151-35A93071-084A-4BC4-9B0E-A6086C9E1012 wds:Q57200151-363C42CF-8E80-4B4C-9B14-F639D6D689C9 wds:Q57200151-27177AD0-064C-4B71-B184-DD796EDFDA43 wds:Q57200151-2BDE9C40-84FA-4A2D-87D5-9DAB7D1E7C17 wds:Q57200151-32FD28A3-6619-429E-86A8-666235908B42 wds:Q57200151-0810A06E-F7D8-4744-8804-BFD07206F965 wds:Q57200151-26E141B8-E32E-484E-8D85-E088DD5AB0BB wds:Q57200151-923E4232-F77A-47AA-9042-154832F21CC2 wds:Q57200151-988AF6AF-709A-4E8C-99B8-19456F26BB18 wds:Q57200151-98AA9464-EFB3-4423-BFB6-39D012670131 wds:Q57200151-8FA53502-6D4B-4644-BDD7-29CA75F2FC72 wds:Q57200151-6FBCA4CF-70F1-43BD-A7EF-D2B05708098D wds:Q57200151-73BB2E5A-D3EF-43FC-8BFF-5A658531354B wds:Q57200151-4A37D06B-4C17-47EB-B4D6-9C0CCC713A8B wds:Q57200151-62B0D75D-B40F-4FBA-9A47-E5BB58C27BF0 wds:Q57200151-EBD082EA-4017-4842-A9CA-A82B681A33CF wds:Q57200151-F8CF98C6-3231-43B3-B90F-B76F1B6490C6 wds:Q57200151-D0AD0AA0-A5A0-4266-946A-2EA18C02C655 wds:Q57200151-EAF0787E-8CB5-4968-A186-F8F3DEC76B59 wds:Q57200151-C9189578-8D5F-4079-86A0-3C43801EE5FA wds:Q57200151-CC060234-DE21-4116-8FA6-A59BC5F184E2 wds:Q57200151-A469A762-0B26-41CA-9A67-435EAA38AD4D wds:Q57200151-FA4E2D58-A9DA-4253-AACC-45EBE92E4FE8 wds:Q57200151-FA9E6BD3-3597-4E07-9679-B437970C1E5A
wdt:P2860
wd:Q39802117 wd:Q34422684 wd:Q45882808 wd:Q36368539 wd:Q37016785 wd:Q83919556 wd:Q37789679 wd:Q40372744 wd:Q58379779 wd:Q35897178 wd:Q59225404 wd:Q44942684 wd:Q49027492 wd:Q34623839 wd:Q83194703 wd:Q40094874 wd:Q28268694 wd:Q60620763 wd:Q52031571 wd:Q49189903 wd:Q37750805 wd:Q39793978 wd:Q41299772 wd:Q59225302 wd:Q59225243 wd:Q59225103 wd:Q28203587 wd:Q79317418
p:P2093
wds:Q57200151-8FC1F546-766F-434A-A218-A1C4D8E88A6B wds:Q57200151-33873542-9193-46E2-AB58-9823D85981E8 wds:Q57200151-A4FC6830-5121-45A0-8A6D-ED0C6D9DFB23 wds:Q57200151-A5B0C730-4DB0-4A09-ADE0-A521670A4A7C wds:Q57200151-AF05718A-430D-4E33-8A90-12D9FC332008
wdt:P2093
Annalisa Palmieri Alex Knowles Daniela Stramazzotti Corrado Rubini Francesco Carinci
rdfs:label
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL
skos:prefLabel
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL
schema:name
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL
p:P50
wds:Q57200151-F33DA64A-9F3D-4B7C-8378-69012990EB6D wds:Q57200151-428F7A95-AE9C-47FE-9DB5-1967B54BC174 wds:Q57200151-581D7A11-B17C-4221-90CF-0AB5DCECFBB6 wds:Q57200151-84DFBADB-EF66-4401-93B0-F446C09CC8AB wds:Q57200151-9EA5D5C8-4193-4922-8FED-1AD90EAF81BC
wdt:P50
wd:Q37372601 wd:Q37372619 wd:Q39507392 wd:Q39507349 wd:Q114717333
p:P1476
wds:Q57200151-684C7C24-E731-4A70-823A-FFDA4F5AC8FD
wdt:P1476
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL
p:P304
wds:Q57200151-A3959389-8E40-42FB-A2CD-05CF76C1DDCD
wdt:P304
810-818
p:P31
wds:Q57200151-BE8ACDAD-F34A-4393-86E7-157008B330B6
wdt:P31
wd:Q13442814
p:P921
wds:Q57200151-3DF23255-1D4A-49D3-BEE1-EDF012952121
wdt:P921
wd:Q61643320
p:P698
wds:Q57200151-F6A2F8D2-6FDF-4FFF-A447-D67FE1E9944F
wdtn:P698
n13:21086019
wdt:P698
21086019
p:P1433
wds:Q57200151-2798ECFD-8E00-41F8-8B34-FDD983FEDB8A
wdt:P1433
wd:Q2312231
p:P433
wds:Q57200151-E6E8757F-C360-46DA-87FF-A0462E25F09A
p:P478
wds:Q57200151-132CD61E-3736-4B46-8F97-00A40B120467
wdt:P433
2
wdt:P478
30
p:P356
wds:Q57200151-DD6A1739-DC4A-4766-A5C2-576B28EF70C3
wdtn:P356
n8:S10637-010-9586-0
wdt:P356
10.1007/S10637-010-9586-0